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Buerger’s disease
Rumi Faizer, MD, and Thomas L. Forbes, MD, London, Ontario, CanadaA 28-year-old female heavy smoker presented after a 1-year history of inter-
mittent, digital gangrene (A), infections of her fingers and toes, and several
episodes of lower extremity superficial thrombophlebitis. This had been managed
with local wound management, analgesics, and several failed attempts at smoking
cessation. Rheumatologic and serologic investigations had proven negative. More
recently, this process had progressed to gangrenous changes involving her right
forefoot and several toes on her left foot. Noninvasive studies and angiography
(B) confirmed occlusive disease isolated to the tibial and pedal arteries and
evidence of corkscrew tibial collaterals (Cover). She underwent a right below-
knee amputation for progressive pain and gangrene. Microscopic examination of
the specimen showed multifocal occlusions with organized thrombi in nonath-
erosclerotic vessels (C).
After several reports in the 1800s and early 1900s, thromboangiitis obliterans,
or Buerger’s disease, was recognized as an arteriopathy distinct from atheroscle-
rosis.1,2 Pathologically the Buerger’s inflammatory process is thought to be
initiated by an intimal antigen that has yet to be identified. It is characterized by
segmental occlusions of distal lower extremity arteries with frequent upper
extremity involvement and venous complications including thrombophlebitis.
Buerger’s disease typically affects young smokers, and although it is more frequent
in male patients, it is becoming increasingly frequent in young women as tobacco
use continues to increase in this population. Pathologic specimens show a
perivascular inflammation involving small and medium-sized arteries, veins, and
nerves, with preservation of the internal elastic lamina differentiating this process
from necrotizing forms of arteritis.
Treatment revolves around smoking cessation and wound management strat-
egies. Other treatment strategies include sympathectomy, prostacyclin analogs,
and newer interventions such as spinal cord stimulation and vascular endothelial
growth factor. Poor results after revascularization attempts have been reported
because of the distal aspect of the disease and the frequent involvement of the
venous conduits. Although smoking cessation is paramount, recurrences are
common with resumption of smoking, with up to 20% of North American
patients eventually requiring major amputation.
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